Blum Robert I

President & CEO, DirectorCYTOKINETICS INC (CYTK) · full profile →Form 4 · filed Aug 10, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$576K
Net Open-Market Flow
-$576K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 10, 2026Option exercise(M)8K$10.60$80K385K
Aug 10, 2026Sell(S)8K$76.76$576K378K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 10, 2026Option exercise(M)8K$0172K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001061983-26-000087) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.